We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 22 results
  1. Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA

    Background

    P2X7 receptor has emerged as a potentially superior PET imaging marker to TSPO, the gold standard for imaging glial reactivity. [ 11 C]SMW139...

    Obada M. Alzghool, Richard Aarnio, ... Merja Haaparanta-Solin in EJNMMI Research
    Article Open access 06 March 2024
  2. PET imaging of P2X7R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [11C]SMW139

    Background

    Non-invasive imaging of the activation status of microglia and the ability to identify a pro- or anti-inflammatory environment can provide...

    Wissam Beaino, Bieneke Janssen, ... Albert D. Windhorst in Journal of Neuroinflammation
    Article Open access 14 October 2020
  3. The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study

    Purpose

    The novel PET tracer [ 11 C]SMW139 binds with high affinity to the P2X 7 receptor, which is expressed on pro-inflammatory microglia. The...

    Marloes H. J. Hagens, Sandeep S. V. Golla, ... Adriaan A. Lammertsma in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 08 November 2019
  4. Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation

    The P2X 7 receptor plays a significant role in microglial activation, and as a potential drug target, the P2X 7 receptor is also an interesting target...

    Bieneke Janssen, Danielle J. Vugts, ... Albert D. Windhorst in Scientific Reports
    Article Open access 26 April 2018
  5. Role of the P2 × 7 receptor in neurodegenerative diseases and its pharmacological properties

    Neurodegenerative diseases seriously affect patients’ physical and mental health, reduce their quality of life, and impose a heavy burden on society....

    Ziyan Hu, Yifan Luo, ... Jialing Hu in Cell & Bioscience
    Article Open access 13 December 2023
  6. Agonists, Antagonists, and Modulators of P2X7 Receptors

    The P2X7 receptor has been proposed as a novel drug target for different types of diseases associated with inflammation, including brain diseases,...
    Christa E. Müller, Vigneshwaran Namasivayam in The P2X7 Receptor
    Protocol 2022
  7. PET Imaging of Purinergic Receptors

    Over the recent years, interest in the purinergic signaling system has sparked in the field of positron emission tomography (PET). Purinergic...
    Bieneke Janssen, Danielle J. Vugts, Albert D. Windhorst in PET and SPECT of Neurobiological Systems
    Chapter 2021
  8. PET Imaging to Measure Neuroinflammation In Vivo

    This paper provides an overview of the role of neuroinflammation in Alzheimer’s disease and other neurodegenerative diseases, highlighting the...
    Maura Malpetti, Nicolai Franzmeier, Matthias Brendel in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  9. Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer’s Disease Continuum

    In the past years, neuroinflammation has been widely investigated in Alzheimer’s disease (AD). Evidence from animal, in vivo and post-mortem studies...

    A. Bieger, A. Rocha, ... Eduardo R. Zimmer in The Journal of Prevention of Alzheimer's Disease
    Article 03 May 2023
  10. Improved syntheses of P2X7 ligands based on substituted benzyl amide of pyroglutamic acid motif labelled with iodine-123 or iodine-125

    Abstract

    P2X 7 sites are emerging targets for molecular imaging research, notably in the context of neurodegeneration and inflammatory conditions....

    Anna Marešová, Michal Jurášek, ... Alexander Popkov in Journal of Radioanalytical and Nuclear Chemistry
    Article Open access 16 August 2023
  11. Microglial Activation and Neuroinflammation

    Several neurological and psychiatric disorders have been associated with neuroinflammation, defined by the activation of microglia and astrocytes in...
    William Charles Kreisl in Hybrid PET/MR Neuroimaging
    Chapter 2022
  12. Mitochondrial dysfunction in the pathogenesis of endothelial dysfunction

    Cardiovascular diseases (CVDs) are a matter of concern worldwide, and mitochondrial dysfunction is one of the major contributing factors. Vascular...

    Suresh Kumar Prajapat, Krushna Ch. Maharana, Sanjiv Singh in Molecular and Cellular Biochemistry
    Article 29 August 2023
  13. PET Biomarkers in Psychiatry

    Positron-emission tomography (PET) is an important tool that allows us to see in vivo biochemical processes in the brain. PET imaging studies in...
    Paulette Orhii, Rajiv Radhakrishnan, Sudhakar Selvaraj in Biomarkers in Neuropsychiatry
    Chapter 2023
  14. PET imaging of neuroinflammation: any credible alternatives to TSPO yet?

    Over the last decades, the role of neuroinflammation in neuropsychiatric conditions has attracted an exponentially growing interest. A key driver for...

    Fabien Chauveau, Alexandra Winkeler, ... Guillaume Becker in Molecular Psychiatry
    Article 13 July 2024
  15. Contribution of Intravital Neuroimaging to Study Animal Models of Multiple Sclerosis

    Multiple sclerosis (MS) is a complex and long-lasting neurodegenerative disease of the central nervous system (CNS), characterized by the loss of...

    Emeline Buttigieg, Anja Scheller, ... Franck Debarbieux in Neurotherapeutics
    Article Open access 18 January 2023
  16. Comprehensive review on design perspective of PET ligands based on β-amyloids, tau and neuroinflammation for diagnostic intervention of Alzheimer’s disease

    Purpose

    Alzheimer’s disease (AD) is a progressive neurodegenerative pathological condition that resulted from the deterioration of cholinergic neurons...

    Parul Mittal, Niharika Singh, ... Puja Panwar Hazari in Clinical and Translational Imaging
    Article 03 February 2021
  17. Molecular Imaging in Neurology

    Radioisotope-based molecular imaging (MI) techniques such as PET/CT and SPECT/CT aim to integrate patient-specific and disease-specific molecular...
    Shankar Vallabhajosula in Molecular Imaging and Targeted Therapy
    Chapter 2023
  18. Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development

    Purpose

    A limit on develo** new treatments for a number of central nervous system (CNS) disorders has been the inadequate understanding of the in...

    Stuart P. McCluskey, Christophe Plisson, ... Oliver Howes in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 21 September 2019
  19. PET and PET/MRI Methods

    The goal of this chapter is to provide the reader with a basic understanding of Positron Emission Tomography (PET) imaging and simultaneous PET and...
    Cristina Lois, Hasan Sari, ... Julie C. Price in Neuroimaging in Schizophrenia
    Chapter 2020
Did you find what you were looking for? Share feedback.